Mobile Financial Headlines

Intermune (ITMN) rises 35%

posted 454 weeks ago on The StockMasters - Financial News, Stock Market Trading, the Best Stocks fo

Shares of Biotechnology company InterMune Inc (NASDAQ: ITMN) are up 35% after announcing a late-stage study of its investigational treatment for a potentially fatal lung disease met the main goal, even as another late-stage trial of the same drug failed. read more

Related Headlines


Search: